Biocon Biologics
Shylashree Baraskar has a strong background in neurology, having worked at prestigious institutions like NIMHANS, KEM Hospital, Jehangir Hospital, and Sahyadri Speciality Hospital. Along with their clinical experience, Shylashree has also ventured into the pharmaceutical industry, holding positions at companies like Mylan Pharmaceuticals, Viatris, and Biocon Biologics. Shylashree has showcased their expertise in clinical development strategy, protocol conceptualization, and managing multinational clinical trials. With a Bachelor of Medicine, Bachelor of Surgery degree from Bangalore Medical College and Research Institute, Shylashree Baraskar continues to make significant contributions in the medical field.
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics